Investigational Drug Details
| Drug ID: | D318 |
| Drug Name: | Promethazine |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB01069 |
| DrugBank Description: | A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. |
| PubChem ID: | 4927 |
| CasNo: | 60-87-7 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C |
| Structure: |
|
| InChiKey: | PWWVAXIEGOYWEE-UHFFFAOYSA-N |
| Molecular Weight: | 284.419 |
| DrugBank Targets: | Histamine H1 receptor; Dopamine D2 receptor; Muscarinic acetylcholine receptor M1; Muscarinic acetylcholine receptor M2; Muscarinic acetylcholine receptor M3; Muscarinic acetylcholine receptor M4; Muscarinic acetylcholine receptor M5; Alpha adrenergic receptor; Calmodulin; Histamine H2 receptor; NA; Voltage-gated sodium channel alpha subunit; NA |
| DrugBank MoA: | Like other H1-antagonists, promethazine competes with free histamine for binding at H1-receptor sites in the GI tract, uterus, large blood vessels, and bronchial muscle. The relief of nausea appears to be related to central anticholinergic actions and may implicate activity on the medullary chemoreceptor trigger zone. |
| DrugBank Pharmacology: | Promethazine, a phenothiazine, is an H1-antagonist with anticholinergic, sedative, and antiemetic effects and some local anesthetic properties. Promethazine is used as an antiemetic or to prevent motion sickness. |
| DrugBank Indication: | For the treatment of allergic disorders, and nausea/vomiting. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|